A5068245141- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Hemodynamic Monitoring and Therapy
- Neuroinflammation and Neurodegeneration Mechanisms
- Cardiac Imaging and Diagnostics
- Heart Failure Treatment and Management
- Atherosclerosis and Cardiovascular Diseases
University of Utah
2024-2025
Intermountain Medical Center
2024
Background Multidisciplinary teams and regionalized care systems have been suggested to improve cardiogenic shock (CS) outcomes. We sought identify clinical factors associated with successful outcomes for patients developing CS at an outside healthcare facility (spoke) being transferred a quaternary medical center (hub). Methods Results Consecutive were evaluated (N=1162). Our study cohort comprised 412 spoke. primary end point was native heart survival (NHS) defined as discharge without...
Type 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity mortality. We sought investigate the effect of glycemia on functional cardiac improvement, morbidity, mortality durable left ventricular assist device (LVAD) recipients.
Background: The pulmonary artery catheter (PAC) is used for hemodynamic monitoring, but its impact on patient outcomes, especially in cardiogenic shock (CS), controversial. Several studies have shown no significant benefits and noted complications, leading to a decline PAC use. However, use appears increased recently guiding management decisions CS. Our study aims assess the clinical characteristics outcomes of CS patients receiving PACs versus not. Methods: We included with admitted...